Literature DB >> 4926376

A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.

C L Meinert, G L Knatterud, T E Prout, C R Klimt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4926376

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  168 in total

1.  Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes study.

Authors:  J McCormack; T Greenhalgh
Journal:  BMJ       Date:  2000-06-24

2.  "Normal" blood glucose and coronary risk.

Authors:  E Barrett-Connor; D L Wingard
Journal:  BMJ       Date:  2001-01-06

Review 3.  Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT.

Authors:  Toni Terry; Kalyani Raravikar; Nalurporn Chokrungvaranon; Peter D Reaven
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

Review 4.  Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?

Authors:  J J Meier; B Gallwitz; W E Schmidt; A Mügge; M A Nauck
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

5.  Kir6.2 is required for adaptation to stress.

Authors:  Leonid V Zingman; Denice M Hodgson; Peter H Bast; Garvan C Kane; Carmen Perez-Terzic; Richard J Gumina; Darko Pucar; Martin Bienengraeber; Petras P Dzeja; Takashi Miki; Susumu Seino; Alexey E Alekseev; Andre Terzic
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

6.  The treatment of diabetic kidney disease.

Authors:  F C Goetz; C M Kjellstrand
Journal:  Diabetologia       Date:  1979-11       Impact factor: 10.122

7.  Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy.

Authors:  Giovanni Corrao; Silvana Antonietta Romio; Antonella Zambon; Luca Merlino; Emanuele Bosi; Marina Scavini
Journal:  Eur J Clin Pharmacol       Date:  2010-11-19       Impact factor: 2.953

8.  Jerome Cornfield's Bayesian approach to assessing interim results in clinical trials.

Authors:  James J Schlesselman
Journal:  J R Soc Med       Date:  2016-01       Impact factor: 5.344

Review 9.  Glucose-Lowering Therapies for Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: State-of-the-Art Review.

Authors:  Salvatore Carbone; Dave L Dixon; Leo F Buckley; Antonio Abbate
Journal:  Mayo Clin Proc       Date:  2018-11       Impact factor: 7.616

Review 10.  Coronary artery disease and diabetes mellitus.

Authors:  Doron Aronson; Elazer R Edelman
Journal:  Cardiol Clin       Date:  2014-06-10       Impact factor: 2.213
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.